Sulsal Haque
University of Cincinnati(US)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Colorectal and Anal Carcinomas, Salivary Gland Tumors Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Transforming growth factor-β: A therapeutic target for cancer(2017)271 cited
- → Pulmonary metastases in pancreatic cancer, is there a survival influence?(2015)58 cited
- → High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma(2018)56 cited
- → Differential expression and prognostic value of long non‐coding RNA in HPV‐negative head and neck squamous cell carcinoma(2018)48 cited
- → Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck(2022)22 cited
- → Lymphopenia as a predictor of survival in chemoradiation (CRT)-treated stage III non-small cell lung cancer (NSCLC).(2015)9 cited
- → A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m2 for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).(2011)7 cited
- → Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy(2017)6 cited
- → High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer(2018)6 cited
- → A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)(2018)5 cited